MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
NVO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Novo-Nordisk A/S (NVO) Ownership - Who owns Novo-Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
267.74B
P/E Ratio
15.18
Total Cash
18.93B
Projected Growth
1.50
Total Debt
99.27B
Revenue
311.94B
Risk (Beta)
0.70
Dividend Yield
0.03
Total Cash/Share
4.26
Total Debt/Equity
2.39
Revenue/Share
11.01 USD as % of share price

Fundamentals

NVO
Capitalization
268B
P/E Ratio
15.18
Risk (Beta)
0.70
Dividend Yield
0.03
Total Cash
18.9B
Total Cash/Share
4.26
Total Debt
99.3B
Total Debt/Equity
2.39
Projected Growth (PEG Ratio)
1.50
Revenue/Share (as % of the share price)
11.01%
Revenue
312B
ROE
N/A
Book Value
168B
P/B Ratio
10.01
Cash Flow
N/A
Earnings
24.97
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
446M
Current Ratio
0.78
Current Revenue Per Employee
980481.44
Dividends Per Share - Security
0.00
EBITDA
154B
Float
N/A
Float - Current
N/A
Gross Income Margin
83.29
Revenue To Assets
26.09
Shares Held By Institutions
58.7B
Shares Outstanding - Current
4.44B
Total Liabilities
314B
Total Volume MTD
N/A
Value
1
Gain YTD
-28.875
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Day Trader: Search for Dip TA&FA ($1500)Day Trader: Search for Dip TA&FA ($1500)
Annualized Return+9%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
NVO
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For NVO
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NVO showed earnings on August 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com